May, M. ; Fritsche, H.-M. ; Gilfrich, C. ; Brookman-May, S. ; Burger, M. ; Otto, W. 
; Bolenz, C. ; Trojan, L. ; Herrmann, E. ; Michel, M.S. ; Wülfing, C. ; Tiemann, A. ; Müller, S.C. ; Ellinger, J. ; Buchner, A. ; Stief, C.G. ; Tilki, D. ; Wieland, W.F. ; Höfner, T. ; Hohenfellner, M. ; Haferkamp, A. ; Roigas, J. ; Müller, O. ; Bretschneider-Ehrenberg, P. ; Zacharias, M. ; Gunia, S. ; Bastian, P.J.
; Bolenz, C. ; Trojan, L. ; Herrmann, E. ; Michel, M.S. ; Wülfing, C. ; Tiemann, A. ; Müller, S.C. ; Ellinger, J. ; Buchner, A. ; Stief, C.G. ; Tilki, D. ; Wieland, W.F. ; Höfner, T. ; Hohenfellner, M. ; Haferkamp, A. ; Roigas, J. ; Müller, O. ; Bretschneider-Ehrenberg, P. ; Zacharias, M. ; Gunia, S. ; Bastian, P.J. 
Zusammenfassung
The therapeutic gold standard of muscle-invasive tumour stages is radical cystectomy (RC), but there are still conflicting reports about associated morbidity and mortality and the oncologic benefit of RC in elderly patients. The aim of the present study was the comparison of overall (OS) and cancer-specific survival (CSS) in patients < 75 and > 75 years of age (median follow-up was 42 months). ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric